Search alternatives:
significant causes » significant cause (Expand Search), significant causal (Expand Search), significant clusters (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
causes increased » cases increased (Expand Search), use increased (Expand Search), values increased (Expand Search)
significant causes » significant cause (Expand Search), significant causal (Expand Search), significant clusters (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
causes increased » cases increased (Expand Search), use increased (Expand Search), values increased (Expand Search)
-
161
-
162
-
163
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
164
-
165
-
166
-
167
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
168
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
169
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
170
-
171
The combination of LPS and PFC caused faster clot initiation and decreased clot strength.
Published 2022“…Both SAL-PFC12 and LPS-PFC3 are significantly decreased from BL levels (*, p < .05); SAL-PFC12 is significantly different from SAL-SAL control (†, p < .05). …”
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
Cumulative mortality percentage in the studied groups during the studied period.
Published 2021Subjects: